The good control of diabetes and a good education on the disease has a memory effect and its health benefits last for years with respect to those who are not so well controlled, according to a study that is presented at the 49 annual meeting of the European Associationfor the study of diabetes (EASD).
Ramón Gómis, director of the IDIBAPS Biomedical Institute, and president of the organizing committee of this International Meeting, which is attendeddisease.
He explained that the results have been obtained from the monitoring of patients who have already participated in a study that occurred fifteen years ago in Barcelona, and that they have continued studying over time.
Dr. Anna Novial, a diabetes specialist at Hospital Clínic-IDIBAPS and only Spanish representative at the Council of the European Diabetes Society, explained that all the results that will be seen these days in this meeting clearly point to the good control of thedisease extends the life of patients and reduces the complications it causes.
Novial has remarked that the decrease in cardiovascular problems such as heart attack, retinopathies, nephropathies or cerebral infarcts, occurs so much in type 2 diabetes, which are those that do not have to inject insulin, as in those of type 1, which are the dependentsof insulin, which is very important for the good management of the sick.
In this regard, he has indicated that there is also a study carried out in Sweden that demonstrates that diabetics that are well controlled have the same life expectancy as non -diabetic, which is socially very important.
Until now, Novial has specified, diabetics have been somewhat marginalized in daily and professional social life, and what is presented these days in Barcelona shows that a diabetic with good control can live normal and do the same things as those that do notThey have the disease.
This meeting will also offer genetic and epigenetic data that confirm that diabetes is a disease that is not only genetic, but that the environment and that lifestyle lead to it and modify the disease, and that not everything is in thegenes
The attendees of this Congress will also know the latest results of new drugs that have been in recent months in the spotlight, and even at risk of being retired, according to Dr. Novials, because it was said that they could cause pancreatirtis or pancreas cancer, and that are safe.
Another demand that will be made from the Catalan capital by companies that develop new technologies for continuous glucose and continuous infusion equipment of insulin, is that it harmonizes a regulation so that the requirements of each country are not different, as occursnow.
Cell therapies, Dr. Anna Novial has remarked, will also be this Congress, and the possibility of looking for easy -to -handling cells and obtaining the skin or umbilical cord, to work on them and turn them into insulin producers.
Pancreas islet transplants against diabetes are also present, although in this case the challenge is to get them out and not be necessary to retransplant at five years.
